| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.008 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.008 |